Colin Hislop Insider Profile
4 Followers
Colin Hislop, CMO at Anthera Pharmaceuticals, holds 23.83K shares in Aravive (Ticker: ARAV), holds 21.04K shares in Anthera Pharmaceuticals (Ticker: ANTH). Most recently, Colin Hislop Sold ― shares of Aravive on Oct 23, 2017 for an estimated value of $1.70K.
Colin Hislop's Trading History
| ARAVAravive | Oct 23, 2017 | ― | Informative Sell | 1.70K | $953.32 | |
| ANTHAnthera Pharmaceuticals | Nov 18, 2015 | CMO | Uninformative Sell | 66.25K | ― |
You May Also Like
Colin Hislop insider profile FAQ
What is the percentage of profitable transactions made by Colin Hislop?
The percentage of profitable transactions made by Colin Hislop is 100%.
What is the average return per transaction made by Colin Hislop?
The average return per transaction made by Colin Hislop is 62.60%.
What stocks does Colin Hislop hold?
Colin Hislop holds: ANTH, ARAV stocks.
What was Colin Hislop’s latest transaction?
Colin Hislop’s latest transaction was an Informative Sell of $1.70K.
What was Colin Hislop's most profitable transaction?
Colin Hislop’s most profitable transaction was an Informative Sell of ARAV stock on October 23, 2017. The return on the trade was 63.00%.
What is Colin Hislop's role in Anthera Pharmaceuticals?
Colin Hislop's role in Anthera Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
